Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients

Regenerative Medicine

Volumn 8, Issue 2, 2013, Pages 145-155

  Rosado De Castro, Paulo Henrique ^a   Schmidt, Felipe Rocha ^a   Battistella, Valeria ^a   Lopes De Souza, Sergio Augusto ^a   Gutfilen, Bianca ^a   Goldenberg, Regina Coeli ^a   Kasai Brunswick, Tais Hanae ^a   Vairo, Leandro ^a   Silva, Rafaella Monteiro ^a   Wajnberg, Eduardo ^a   Do Brasil, Pedro Emmanuel ^b   Gasparetto, Emerson Leandro ^a   Maiolino, Angelo ^a   Alves Leon, Soniza Vieira ^a   Andre, Charles ^a   Mendez Otero, Rosalia ^a   De Freitas, Gabriel Rodriguez ^a   Barbosa Da Fonseca, Lea Mirian ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

Author keywords

99mTc; bone marrow mononuclear cells; cell transplatation; cerebral infarct; scinitigraphy

Indexed keywords

TECHNETIUM 99M;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; BRAIN; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL LABELING; CELL SEPARATION; CELL SUSPENSION; CELLULAR DISTRIBUTION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; LUNG; MALE; MONONUCLEAR CELL; NEUROIMAGING; NEUROLOGIC EXAMINATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPLEEN; WHOLE BODY SCINTISCANNING;

BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; LEUKOCYTES, MONONUCLEAR; RADIONUCLIDE IMAGING; STROKE; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84874904297     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.13.2     Document Type: Article

References (57)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349(9061), 1269-1276 (1997).
2. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 371(9624), 1612-1623 (2008).
3. Molina CA. Reperfusion therapies for acute ischemic stroke: current pharmacological and mechanical approaches. Stroke 42(1 Suppl.), S16-S19 (2011).
4. Hess DC, Hill WD. Cell therapy for ischaemic stroke. Cell Prolif. 44(Suppl. 1), 1-8 (2011).
5. Mendez-Otero R, De Freitas GR, Andre C, De Mendonca ML, Friedrich M, Oliveira-Filho J. Potential roles of bone marrow stem cells in stroke therapy. Regen. Med. 2(4), 417-423 (2007).
6. Bliss TM, Andres RH, Steinberg GK. Optimizing the success of cell transplantation therapy for stroke. Neurobiol. Dis. 37(2), 275-283 (2010).
7. Battistella V, De Freitas GR, Da Fonseca LM et al. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen. Med. 6(1), 45-52 (2011).
8. Barbosa Da Fonseca LM, Gutfilen B, Rosado De Castro PH et al. Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection. Exp. Neurol. 221(1), 122-128 (2010).
9. Barbosa Da Fonseca LM, Battistella V, De Freitas GR et al. Early tissue distribution of bone marrow mononuclear cells after intra-arterial delivery in a patient with chronic stroke. Circulation 120(6), 539-541 (2009).
10. Barbosa Da Fonseca LM, Xavier SS, Rosado De Castro PH et al. Biodistribution of bone marrow mononuclear cells in chronic chagasic cardiomyopathy after intracoronary injection. Int. J. Cardiol. 149(3), 310-314 (2011).
11. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Austria (2008).
12. Chen J, Li Y, Wang L et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32(4), 1005-1011 (2001).
13. Chen J, Zhang ZG, Li Y et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ. Res. 92(6), 692-699 (2003).
14. Chopp M, Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol. 1(2), 92-100 (2002).
15. Li Y, Chen J, Wang L, Lu M, Chopp M. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56(12), 1666-1672 (2001).
16. Li Y, Chopp M, Chen J et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J. Cereb. Blood Flow Metab. 20(9), 1311-1319 (2000).
17. Giraldi-Guimaraes A, Rezende-Lima M, Bruno FP, Mendez-Otero R. Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats. Brain Res. 1266, 108-120 (2009).
18. Kamiya N, Ueda M, Igarashi H et al. Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sci. 83(11-12), 433-437 (2008).
19. De Vasconcelos Dos Santos A, Da Costa Reis J, Diaz Paredes B et al. Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats. Brain Res. 1306, 149-158 (2010).
20. Burt RK, Loh Y, Pearce W et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 299(8), 925-936 (2008).
21. Resnick IB, Shapira MY, Slavin S. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases. Transpl. Immunol. 14(3-4), 207-219 (2005).
22. Kondziolka D, Wechsler L, Goldstein S et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55(4), 565-569 (2000).
23. Kondziolka D, Steinberg GK, Wechsler L et al. Neurotransplantation for patients with subcortical motor stroke: a Phase 2 randomized trial. J. Neurosurg. 103(1), 38-45 (2005).
24. Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc. Dis. 20(2), 101-107 (2005).
25. Suarez-Monteagudo C, Hernandez-Ramirez P, Alvarez-Gonzalez L et al. Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study. Restor. Neurol. Neurosci. 27(3), 151-161 (2009).
26. Walczak P, Zhang J, Gilad AA et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 39(5), 1569-1574 (2008).
27. Hicks A, Jolkkonen J. Challenges and possibilities of intravascular cell therapy in stroke. Acta Neurobiol. Exp. (Wars) 69(1), 1-11 (2009).
28. Borlongan CV, Hadman M, Sanberg CD, Sanberg PR. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 35(10), 2385-2389 (2004).
29. Sarnowska A, Braun H, Sauerzweig S, Reymann KG. The neuroprotective effect of bone marrow stem cells is not dependent on direct cell contact with hypoxic injured tissue. Exp. Neurol. 215(2), 317-327 (2009).
30. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57(6), 874-882 (2005).
31. Lee JS, Hong JM, Moon GJ et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28(6), 1099-1106 (2010).
32. Shen LH, Li Y, Chen J et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J. Cereb. Blood Flow Metab. 27(1), 6-13 (2007).
33. Hill WD, Hess DC, Martin-Studdard A et al. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J. Neuropathol. Exp. Neurol. 63(1), 84-96 (2004).
34. Honmou O, Houkin K, Matsunaga T et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134(Pt 6), 1790-1807 (2011).
35. Savitz SI, Misra V, Kasam M et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann. Neurol. 70(1), 59-69 (2011).
36. Correa PL, Mesquita CT, Felix RM et al. Assessment of intra-arterial injected autologous bone marrow mononuclear cell distribution by radioactive labeling in acute ischemic stroke. Clin. Nucl. Med. 32(11), 839-841 (2007).
37. Mendonca ML, Freitas GR, Silva SA et al. [Safety of intra-arterial autologous bone marrow mononuclear cell transplantation for acute ischemic stroke]. Arq Bras Cardiol. 86(1), 52-55 (2006).
38. De Freitas GR, Mendonca ML, Bezerra DC et al. Safety and feasibility of intra-arterial autologous bone marrow mononuclear cell transplantation in acute ischemic stroke. Stroke 37(2), 624-625 (2006).
39. Friedrich MA, Martins MP, Araujo MD et al. Intra-arterial infusion of autologous bone-marrow mononuclear cells in patients with moderate to severe middle-cerebral-artery acute ischemic stroke. Cell Transplant. 21(Suppl. 1), S13-S21 (2012).
40. Moniche F, Gonzalez A, Gonzalez-Marcos JR et al. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke 43(8), 2242-2244 (2012).
41. Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke 35(7), 1769-1775 (2004).
42. Lamy C, Domigo V, Semah F et al. Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology 60(3), 400-404 (2003).
43. Bladin CF, Alexandrov AV, Bellavance A et al. Seizures after stroke: a prospective multicenter study. Arch. Neurol. 57(11), 1617-1622 (2000).
44. Palestro CJ, Love C, Bhargava KK. Labeled leukocyte imaging: current status and future directions. Q. J. Nucl. Med. Mol. Imaging 53(1), 105-123 (2009).
45. Lappalainen RS, Narkilahti S, Huhtala T et al. The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats. Neurosci. Lett. 440(3), 246-250 (2008).
46. Detante O, Moisan A, Dimastromatteo J et al. Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution. Cell Transplant. 18(12), 1369-1379 (2009).
47. Vasconcelos-Dos-Santos AI, Rosado-De-Castro PH, Lopes De Souza SA et al. Intravenous and intra-arterial administration of bone marrow mononuclear cells after focal cerebral ischemia: is there a difference in biodistribution and efficacy? Stem Cell Res. 9(1), 1-8 (2012).
48. Mitkari B, Kerkela E, Nystedt J et al. Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats. Exp. Neurol. 239, 158-162 (2012).
49. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169(1), 12-20 (2001).
50. Carvalho AB, Quintanilha LF, Dias JV et al. Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells 26(5), 1307-1314 (2008).
51. Daldrup-Link HE, Rudelius M, Metz S et al. Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy. Eur. J. Nucl. Med. Mol. Imaging 31(9), 1312-1321 (2004).
52. Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP. Stem cell transplantation: the lung barrier. Transplant. Proc. 39(2), 573-576 (2007).
53. Fischer UM, Harting MT, Jimenez F et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 18(5), 683-692 (2009).
54. Lee RH, Pulin AA, Seo MJ et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5(1), 54-63 (2009).
55. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab. 26(5), 654-665 (2006).
56. Offner H, Subramanian S, Parker SM et al. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J. Immunol. 176(11), 6523-6531 (2006).
57. Schwarting S, Litwak S, Hao W, Bahr M, Weise J, Neumann H. Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke 39(10), 2867-2875 (2008).